Vastera Stock

Vastera is a biotech company with the primary goal of developing groundbreaking treatments for cardiovascular and cancer diseases.

Sign up today and learn more about Vastera Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Vastera Stock

Bastera is a biotech company with the primary goal of developing groundbreaking treatments for cardiovascular and cancer diseases. Their approach involves targeting new redox signaling pathways, aiming to pioneer "first-in-class" therapies in these fields. Vastera was established in 2018 when SangWon Kang, a professor at Ewha Womans University, transferred a patent based on research results on redox signaling in blood vessels and cancer.

Funding History

November 2020$5.5B
March 2022$18.0B

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo